ASTEPRO 0.15%—the Earlier the Better

  • Symptom relief right at the site
  • Treats nasal symptoms, including congestion, itchy nose, runny nose, and sneezing, without an added decongestant1,2
  • Indicated for seasonal and perennial allergic rhinitis1
  • ASTEPRO 0.15% has no generic equivalent
    - Contains 50% higher concentration per spray than azelastine HCI 0.1%
  • ASTEPRO 0.15% provides trial samples that last 3–5 days
  • 1 Rx;
  • 1 Copay;
  • Nearly 2 Months of Therapy
astepro
allergy
Get the Allergy Information You Need–the Earlier the Better With the

Allergy Advisor

Mobile Application
 
 

For Physicians

#1 Prescribed Branded Antihistamine

For Pharmacists

Highest Tier 2 availability

For Patients

Read more about ASTEPRO 0.15% and the allergy symptom relief it delivers
 

mobile information
 

Indication

ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.

Important Risk Information

  • Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
  • Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
  • In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
  • Pregnancy Category C: Based on animal data, may cause fetal harm
    Please see full Prescribing Information
    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088

    For more information about ASTEPRO Nasal Spray 0.15%, call Meda Pharmaceuticals Inc. at 1-800-526-3840.